Reine Allan
Prime Medicine, Inc. · Chief Executive Officer
Reine Allan is listed in public filings as director, officer: Chief Executive Officer. This Reine Allan insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Prime Medicine, Inc. (PRME). Investors use Reine Allan's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $5.7M1.3M shares | Grant / ExerciseFeb 26, 2026 | $5.7M1.3M shares | $4.38 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $0850k shares | OtherAug 1, 2025 | $5.8M850k shares | $6.80 | -- | |
| $3.4M850k shares | Grant / ExerciseAug 1, 2025 | $3.4M850k shares | $4.04 | -- | |
| $147k125k shares | BuyMay 21, 2025 | $147.2K125k shares | $1.18 | -- | |
| $2.7M2M shares | Grant / ExerciseMay 19, 2025 | $2.7M2M shares | $1.34 | -- | |
| $5.8M850k shares | Grant / ExerciseMay 8, 2025 | $510.0K75k shares | $6.80 | -- | |
| $666k275k shares | Grant / ExerciseFeb 27, 2025 | $665.5K275k shares | $2.42 | -- | |
| $5.3M775k shares | Grant / ExerciseDec 5, 2024 | $510.0K75k shares | $6.80 | -- |